Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Clinical trial NCT02532218 · UNKNOWN
Trial details
- NCT number
- NCT02532218
- Sponsor
- Arisaph Pharmaceuticals Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-09-01
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.